Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Primary biliary cirrhosis (PBC)-autoimmune hepatitis (AIH) overlap syndrome is used to describe the coexistence of both diseases, with either a sequential or a simultaneous presentation in the same patient. Available studies have focused on the simultaneous form, whereas there is limited information on sequential PBC-AIH. We carried out a retrospective study of patients who sequentially developed PBC-AIH overlap syndrome. METHODS: The medical data of 1065 patients diagnosed with PBC (n=483) and AIH (n=582) were retrospectively analyzed. RESULTS: A sequential development of PBC-AIH was observed in 19 (1.8%) patients after a mean of 6.5 (1-14) years of follow-up. AIH developed in 12 (2.5%) PBC patients, whereas PBC occurred in seven (1.2%) patients with AIH. The baseline serologic and histological findings of patients who developed PBC-AIH were similar to those of patients with typical PBC or AIH. Eighteen patients were treated with a combination of ursodeoxycholic acid (UDCA) and immunosuppression after the diagnosis of PBC-AIH was established. One patient showed a spontaneous resolution of hepatitic flare under UDCA therapy. Biochemical remission was achieved in 16 patients, whereas three progressed to decompensated cirrhosis and required liver transplantation. CONCLUSION: The sequential overlap of PBC-AIH can occur during the follow-up of patients with pure PBC or AIH. In our cohort, we could not identify any factors that predicted the development of this rare condition. The combination of UDCA and immunosuppression seems to be an appropriate therapy in the setting of PBC-AIH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This combined treatment regime has been used in patients with PBC and features of AIH with high response rates [160,161,175,180].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [161]
In the citing paper
“PBC patients under UDCA treatment may develop increasing hepatitis activity even years after the initial PBC diagnosis was made [161,160].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [161]
Citations
Cites
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
Frequency and nature of the variant syndromes of autoimmune liver disease
Czaja, A. J. (1998) · Hepatology · doi:10.1002/hep.510280210 · Cited by 343
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
Dalekos, G., Gatselis, N., Drenth, J. P. H., Heneghan, M., Jørgensen, M., Lohse, A. W., Londoño, M., Muratori, L., Papp, M., Samyn, M., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.03.017 · Cited by 231
Self-citationCurrent and potential treatments for primary biliary cholangitis
Shah, R. A., & Kowdley, K. V. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30343-7 · Cited by 115
Role of Histopathology in Autoimmune Hepatitis
TINIAKOS, D. G., Brain, J. G., & Bury, Y. A. (2015) · Digestive Diseases · doi:10.1159/000440747 · Cited by 119
Metadata
- Authors
- Efe, C., Ozaslan, E., Heurgué-Berlot, A., Kav, T., Masi, C., Purnak, T., Torgutalp, M., Muratori, L., Bresson-Hadni, S., Thiéfin, G., Schiano, T. D., Muratori, P., & Wahlin, S.
- Affiliations
- Mount Sinai Health System (US)
- Hacettepe University (TR)
- University of Bologna (IT)
- Centre Hospitalier Universitaire de Reims (FR)
- Mount Sinai Hospital (US)
- Corresponding author
- Efe, Cumali
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2014-05
- Volume
- 26
- Issue
- 5
- Pages
- 532-537
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W2052576965
- Semantic Scholar
- 92c9dd026540376c439bec14832a0983d8d0db2f
- Cited by
- 32
- References
- 42
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2022: 2 · 2021: 3 · 2020: 7 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 3
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Alberta Innovates - Health Solutions
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, autoimmune hepatitis, PBC-AIH overlap syndrome, ursodeoxycholic acid, immunosuppression, biochemical remission, liver transplantation, decompensated cirrhosis
- MeSH terms
- Adolescent, Adult, Aged, Drug Therapy, Combination, Europe, Female, Gastrointestinal Agents, Humans, Immunosuppressive Agents, Liver, Liver Cirrhosis, Biliary, Male, Middle Aged, Remission Induction, Retrospective Studies, Risk Factors, Syndrome, Time Factors, United States, Ursodeoxycholic Acid, Biomarkers, Liver Transplantation, Treatment Outcome, Disease Progression, Hepatitis, Autoimmune, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. https://app.cochat.ai/papers/10.1097/meg.0000000000000075
- The paper
- Efe, C., Ozaslan, E., Heurgué-Berlot, A., Kav, T., Masi, C., Purnak, T., Torgutalp, M., Muratori, L., Bresson-Hadni, S., Thiéfin, G., Schiano, T. D., Muratori, P., & Wahlin, S. (2014). Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000000075
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.